Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases
| Status: | Recruiting | 
|---|---|
| Conditions: | Blood Cancer, Endocrine, Hematology | 
| Therapuetic Areas: | Endocrinology, Hematology, Oncology | 
| Healthy: | No | 
| Age Range: | Any - 20 | 
| Updated: | 5/9/2018 | 
| Start Date: | December 2001 | 
| End Date: | December 2021 | 
| Contact: | Lisa Murray, MA, CCRP | 
| Email: | Murray_L@kids.wustl.edu | 
| Phone: | 3144544240 | 
A Study of Hematopoietic Stem Cell Transplantation (HSCT) in Non-Malignant Disease Using a Reduced-Intensity Preparatory Regime
The hypothesis for this study is that a preparative regimen that maximizes host
immunosuppression without myeloablation will be well tolerated and sufficient for engraftment
of donor hematopoietic cells. It is also to determine major toxicities from these
conditioning regimens, within the first 100 days after transplantation.
			immunosuppression without myeloablation will be well tolerated and sufficient for engraftment
of donor hematopoietic cells. It is also to determine major toxicities from these
conditioning regimens, within the first 100 days after transplantation.
Inclusion Criteria:
Stratum 1: Patient must have a hemoglobinopathy receiving a matched related transplant with
bone marrow or peripheral blood stem cells.
Stratum 2: Patient must have thalassemia receiving an unrelated donor transplant with bone
marrow or umbilical cord blood stem cells.
Stratum 3: Patient must have a hemoglobinopathy receiving a minimally mismatched unrelated
donor transplant with bone marrow or single or double umbilical cord blood product.
Stratum 4: Patient must have a non-malignant disorder (excluding hemoglobinopathy)
receiving a minor mismatched unrelated donor transplant with bone marrow or single or
double umbilical cord blood product.
All strata:
- Recipient age < 21 years
- Lansky/Karnofsky >/= 40
- Adequate pulmonary, renal, liver, and other organ function as defined in protocol
- Negative pregnancy test
- Adequate total nucleated cell or CD34+ dose of product as defined in protocol
- If sickle cell, Hemoglobin S <45%
Exclusion Criteria:
- HIV positive
- Invasive infection
- Pregnancy/lactating
We found this trial at
    18
    sites
	
									1000 Blythe Blvd
Charlotte, North Carolina 28203
	
			Charlotte, North Carolina 28203
(704) 355-2000
							
					Principal Investigator: Michael Eckrich, MD
			
						
								Click here to add this to my saved trials
	
								Miami, Florida 33124			
	
			(305) 284-2211
							
					Principal Investigator: Martin Andreansky, MD
			
						
								
		University of Miami A private research university with more than 15,000 students from around the...  
  
  Click here to add this to my saved trials
	
									3100 SW 62nd Ave
Miami, Florida 33155
	
			Miami, Florida 33155
(305) 666-6511
							
					Principal Investigator: Kamar Godder, MD
			
						
								
		Miami Children's Hospital Welcome to Miami Children  
  
  Click here to add this to my saved trials
	Click here to add this to my saved trials
	
									2301 Erwin Rd
Durham, North Carolina 27710
	
			Durham, North Carolina 27710
919-684-8111
							
					Principal Investigator: Suhag Parikh, MD
			
						
								
		Duke Univ Med Ctr As a world-class academic and health care system, Duke Medicine strives...  
  
  Click here to add this to my saved trials
	
									30 Prospect Ave
Hackensack, New Jersey 07601
	
			Hackensack, New Jersey 07601
(201) 996-2000
							
					Principal Investigator: Alfred Gillio, MD
			
						
								
		Hackensack University Medical Center Hackensack University Medical Center, part of the Hackensack University Health Network,...  
  
  Click here to add this to my saved trials
	
									340 W 10th St #6200
Indianapolis, Indiana 46202
	
			Indianapolis, Indiana 46202
(317) 274-3772
							
					Principal Investigator: Paul Haut, MD
			
						
								
		Indiana University School of Medicine With more than 2,000 students in 2013, the Indiana University...  
  
  Click here to add this to my saved trials
	
								Kansas City, Missouri 64108			
	
			
					Principal Investigator: Jignesh Dalal, MD
			
						
								Click here to add this to my saved trials
	Click here to add this to my saved trials
	
									630 W 168th St
New York, New York
	
			New York, New York
212-305-2862 
							
					Principal Investigator: Monica Bhatia, MD
			
						
								
		Columbia University Medical Center Situated on a 20-acre campus in Northern Manhattan and accounting for...  
  
  Click here to add this to my saved trials
	
									1919 E Thomas Rd
Phoenix, Arizona 85006
	
			Phoenix, Arizona 85006
(602) 933-1000
							
					Principal Investigator: Roberta Adams, MD
			
						
								
		Phoenix Children's Hospital Phoenix Children's Hospital has provided hope, healing, and the best healthcare for...  
  
  Click here to add this to my saved trials
	Click here to add this to my saved trials
	
									660 South Euclid Avenue
Saint Louis, Missouri 63110
	
			
					Saint Louis, Missouri 63110
Phone: 314-454-6018
					Click here to add this to my saved trials
	Click here to add this to my saved trials
	Click here to add this to my saved trials
	Click here to add this to my saved trials
	
								Washington, District of Columbia 20037			
	
			
					Principal Investigator: David Jacobsohn, MD
			
						
								Click here to add this to my saved trials
	Click here to add this to my saved trials